The effects of L- Dopa and N-(alpha-linolenoyl) Tyrosine on 6-OH-DA lesions on dopamine level and activity, dyskinesia and homocysteimia

Research output: Contribution to journalArticlepeer-review

Abstract

The three major issues in L-DOPA therapy for Parkinson are: 1) rapid tolerance; 2) induced dyskinesia; 3) hyperhomocysteinemia. The newly synthesized molecule, which is an amide bond molecule composed of L-tyrosine and alphalinolenic acid, i.e., N-(alpha-linolenoyl) tyrosine (NLT), represents a new class of molecules that combines essential amino acids with essential fatty acids. This study demonstrates that acute administration of NLT results in prolonged increase of the brain dopamine level, and that this molecule is able to overcome the three major problems associated with Parkinson’s L-DOPA therapy: it is able to elevate brain dopamine levels and increase activity, without inducing tolerance, dyskinesia or hyperhomocysteinemia.
Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalAdvances in Parkinson's Disease
Volume02
Issue number01
DOIs
StatePublished - 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'The effects of L- Dopa and N-(alpha-linolenoyl) Tyrosine on 6-OH-DA lesions on dopamine level and activity, dyskinesia and homocysteimia'. Together they form a unique fingerprint.

Cite this